Personalized Evidence-based Medicine in Patients With Atrial Fibrillation
Condition(s):Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for StrokeLast Updated:March 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for StrokeLast Updated:March 1, 2021Completed
Condition(s):Hepatic Cancer; Metastatic Cancer; Chemotherapy EffectLast Updated:February 21, 2021Recruiting
Condition(s):Pancreatic Cancer; Bile Duct Cancer; Ampulla of Vater CancerLast Updated:February 21, 2021Recruiting
Condition(s):Shoulder Osteoarthritis; Proximal Humeral Fracture; Avascular Necrosis of HumerusLast Updated:February 21, 2021Recruiting
Condition(s):Chronic Venous InsufficiencyLast Updated:February 17, 2021Not yet recruiting
Condition(s):BioequivalenceLast Updated:February 15, 2021Not yet recruiting
Condition(s):The Neoadjuvant TherapyLast Updated:February 15, 2021Active, not recruiting
Condition(s):Bladder CancerLast Updated:February 21, 2021Recruiting
Condition(s):Secondary Hyperparathyroidism; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Hypocalcemia; HypoparathyroidismLast Updated:February 11, 2021Enrolling by invitation
Condition(s):COVID-19Last Updated:February 15, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.